EN
HI
Summary
As of 17 Oct, 2026, Aurobindo Pharma stock price is ₹1666.9. During the trading session, the stock has moved between an intraday low of ₹1655.00 and an intraday high of ₹1681.70. Over the last 52 weeks, Aurobindo Pharma has traded between ₹1080.10 and ₹1740.00.
The stock has recorded a trading volume of 7,96,734 shares,. Its Average Traded Price (ATP) is ₹1664.90, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 69 @ ₹1666.90.
Aurobindo Pharma has an upper circuit limit of ₹1833.50 and a lower circuit limit of ₹1500.30. The total value traded stands at ₹132.65 CR, and the delivery percentage for the day is 55.59%.
The stock is currently traded with a market lot size of 1. Aurobindo Pharma also offers a dividend yield of 0.24%.
Aurobindo Pharma Share Price Chart
Aurobindo Pharma Share Key Metrics
Volume
7.97 L
Market Cap
95909.74 CR
LTQ@LTP
69@1666.90
ATP
1664.9
Var Margin
14.06 %
Circuit Range
1500.3-1833.5
Delivery %
55.59 %
Value
132.65 CR
ASM/GSM
No
Market Lot
1
Aurobindo Pharma Fundamentals
P/E Ratio
25.73
P/B Ratio
2.45
Div. Yield
0.24
Sector P/E
40.5
Sector P/B
3.42
Sec. Div. Yield
0.52
Aurobindo Pharma Resistance and Support
Pivot 1669.77
Resistance
First Resistance
1692.44
Second Resistance
1706.97
Third Resistance
1729.64
Support
First Support
1655.24
Second Support
1632.57
Third Support
1618.04
Aurobindo Pharma Futures & Options
Aurobindo Pharma Option Chain
View Price, OI, Greeks & More...
27OCT26
1669.20
-9.00 (0.54%)
23NOV26
1669.20
-19.40 (1.15%)
29DEC26
1683.00
-12.50 (0.74%)
AUROPHARMA|27OCT26 CE 1660.00
30.20
-8.15 (-21.25%)
AUROPHARMA|27OCT26 PE 1680.00
33.35
3.6 (12.1%)
Aurobindo Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 16 2026 | 1677.9 | 1666.9 | -0.66% | 1681.7 | 1655 |
| Thu Oct 15 2026 | 1653.19 | 1677.9 | 0.90% | 1684.3 | 1647.09 |
| Wed Oct 14 2026 | 1684 | 1662.9 | -1.29% | 1687.69 | 1654.09 |
Aurobindo Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-04-06 | Buy Back of Shares |
| 2026-02-09 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-08-04 | Quarterly Results & Interim Dividend |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-10 | Quarterly Results |
Aurobindo Pharma News
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Aurobindo Pharma has received final approval from the USFDA to manufacture and market Perampanel Tablets. The approved product has an estimated market size of US$ 67 million and is scheduled for commercial launch in Q3 FY27.
Oct 03 2026 17:09:24
Aurobindo Pharma Ltd - 524804 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Aurobindo Pharma's wholly-owned subsidiary Apitoria has completed the acquisition of an 80% stake in A1 Biochem Labs' Contract Research Services business. The move grants access to a CRO platform with over 50 clients and 800 completed projects.
Oct 02 2026 18:35:03
Read More
Aurobindo Pharma Management
| Name | Position |
|---|---|
| Mangalam Ramasubramanian Kumar | Chairman |
| K Nityananda Reddy | Vice Chairman & Managing Director |
Aurobindo Pharma Similar Stocks
Zydus Lifesciences Ltd.
1123.00
-17.20 (1.51%)
Laurus Labs Ltd.
2060.10
41.60 (2.06%)
Cipla Ltd.
1325.10
-2.90 (0.22%)
Dr. Reddy's Laboratories Ltd.
1233.00
14.20 (1.17%)
Mankind Pharma Ltd.
2275.50
-72.10 (3.07%)
Lupin Ltd.
1961.60
-19.30 (0.97%)
Manipal Health Enterprises Ltd.
642.40
0.70 (0.11%)
Max Healthcare Institute Ltd.
846.00
-12.00 (1.40%)
Glenmark Pharmaceuticals Ltd.
2226.70
-23.80 (1.06%)
Alkem Laboratories Ltd.
5050.00
-70.50 (1.38%)
Aurobindo Pharma FAQs
The Buying Price of Aurobindo Pharma share is 1666.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aurobindo Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aurobindo Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aurobindo Pharma shares is 25.73. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aurobindo Pharma shares is 2.45. Useful to assess the stock's value relative to its book value.
To assess Aurobindo Pharma’s valuation compare Sector P/E, P/B which are 40.5 & 3.42 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aurobindo Pharma is 95909.74 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aurobindo Pharma share price is 1740.00 & 1080.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aurobindo Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in AUROPHARMA
Or Download Choice FinX App
Invest in AUROPHARMA
